NDC 17033-451 - Clavacillin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17033-451
- Package NDCs from labels
- 17033-451-15
- Manufacturer
- Dechra Veterinary Products, LLC
- Effective date
- 2026-04-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Clavacillin - Dechra Veterinary Products, LLC | Dechra Veterinary Products, LLC | 2026-04-03 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17033-451-15 | Clavacillin | 15 mL in 1 VIAL, GLASS | POWDER, FOR SUSPENSION | 15 | 5 | |
| 17033-451-15 | Clavacillin | 1 in 1 CARTON | POWDER, FOR SUSPENSION | 1 | 5 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Augmentin | AMOXICILLIN AND CLAVULANATE POTASSIUM | Allegis Holdings, LLC | 04a31a42-d79e-bbb4-e063-6394a90a63ee | 2024-05-16 | Warnings, Adverse reactions | Q42OMW3AT8 804826J2HU |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | A-S Medication Solutions | 2718248d-d948-466e-959b-1a972519f108 | 2024-05-14 | Warnings, Adverse reactions | Q42OMW3AT8 804826J2HU |
| Amoxicillin | AMOXICILLIN | A-S Medication Solutions | 14a5f8c2-fdaf-4ad4-982b-c5aa128e242d | 2024-05-06 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin | AMOXICILLIN | A-S Medication Solutions | 7db086c6-a56b-4848-9eec-abaaff9f5b6f | 2024-05-01 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin | AMOXICILLIN | A-S Medication Solutions | d5ecb620-5267-4dcf-be81-64c7766516f5 | 2024-05-01 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin | AMOXICILLIN | A-S Medication Solutions | a2a5bb34-671b-499c-b8b4-c40fb51af09a | 2024-04-30 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin | AMOXICILLIN | A-S Medication Solutions | 3d8a700b-b23b-459a-a19a-213dd39b6a3a | 2024-04-30 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin | AMOXICILLIN | A-S Medication Solutions | efc66d77-1733-41e1-9aed-7c10a4b4ba96 | 2024-04-30 | Warnings, Adverse reactions | 804826J2HU |
| AMOXICILLIN AND CLAVULANATE POTASSIUM | AMOXICILLIN AND CLAVULANATE POTASSIUM | A-S Medication Solutions | 00cf4429-e37c-4490-b22d-3cd796124296 | 2024-04-30 | Warnings, Adverse reactions | Q42OMW3AT8 804826J2HU |
| Amoxicillin | AMOXICILLIN | A-S Medication Solutions | 6a3d1af5-6e93-4f06-8d82-1c87290c46aa | 2024-04-30 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin | AMOXICILLIN | A-S Medication Solutions | 1dc5cc5a-59ba-4bc9-b581-cb7b70ce2652 | 2024-04-30 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin | AMOXICILLIN | A-S Medication Solutions | 322feb95-8bd4-440a-bda2-29ee19b11234 | 2024-04-15 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin | AMOXICILLIN | A-S Medication Solutions | 4d0f063a-d896-4757-8f22-9614e2ad71d4 | 2024-04-11 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin | AMOXICILLIN | A-S Medication Solutions | 73219f24-6eac-4472-b2a7-cad36936c185 | 2024-04-11 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin | AMOXICILLIN | A-S Medication Solutions | 26202694-cf20-4b08-90cc-70a3d30cbb0f | 2024-04-11 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin | AMOXICILLIN | NorthStar Rx LLC | 843f6053-63d9-47d2-81f1-b6aa78a7c20c | 2024-03-02 | Warnings, Adverse reactions | 804826J2HU |
| AMOXICILLIN AND CLAVULANATE POTASSIUM | AMOXICILLIN AND CLAVULANATE POTASSIUM | Medsource Pharmaceuticals | 12a00e7e-80f5-7c5e-e063-6394a90a68d2 | 2024-03-01 | Warnings, Adverse reactions | Q42OMW3AT8 804826J2HU |
| Amoxicillin | AMOXICILLIN | Proficient Rx LP | 6a9cfa97-3715-4b75-a1e3-932a34a942d4 | 2024-03-01 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Medsource Pharmaceuticals | 1275ad58-c53f-20d0-e063-6394a90a4a43 | 2024-02-28 | Warnings, Adverse reactions | Q42OMW3AT8 804826J2HU |
| Amoxicillin | AMOXICILLIN | Hikma Pharmaceuticals USA Inc. | c8591c2a-92ef-4432-b19a-bb46063047ee | 2024-02-28 | Warnings, Adverse reactions | 804826J2HU |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.